AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study

BACKGROUND: Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated in breast cancer. OBJECTIVE: This case-controlled pilot study evaluated the serum level of AKR1B10 in healthy women and patients with a localized or metastatic breast cancer. METHODS: AKR1B10 levels were measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhe, Delfino, Kristin, Tiwari, Vivek, Wang, Xin, Hannan, Abdul, Zaidi, Fawwad, McClintock, Andrew, Robinson, Kathy, Zhu, Yun, Gao, John, Cao, Deliang, Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908957/
https://www.ncbi.nlm.nih.gov/pubmed/35280770
http://dx.doi.org/10.3389/fonc.2022.727505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908957/
https://www.ncbi.nlm.nih.gov/pubmed/35280770
http://dx.doi.org/10.3389/fonc.2022.727505

Ejemplares similares